and HCC patients were diagnosed according to the criteria as previously described (1, 11).
and -DP. The importance of polymorphic residues in HBV peptide binding and T cell 90 recognition, mainly in the HLA-DR and HLA-DQ molecules, has been intensely studied.
91
However, less is known about HLA-DP molecules. A recent genome-wide association study
92
(GWAS) revealed that 11 single nucleotide polymorphisms (SNPs) in the HLA-DPA1 and
93
HLA-DPB1 regions were significantly associated with HBV persistence in Asians (26).
94
Subsequent studies further reported that some of the 11 SNPs were significantly associated 95 with HBV persistence/clearance in Eastern Asians (27) (28) (29) (30) (31) (32) . The associations of HLA-DP
96
SNPs and HBV-caused advanced liver diseases have not been fully elucidated except one 97 study reporting a borderline significant effect of rs3077 on genetic susceptibility to HCC (28).
98
The effects of HLA SNPs on the generation of HC-or HCC-related HBV mutations and their
99
interactions on the outcomes of HBV infection have not been reported. HLA SNPs on the risks of HC and HCC were also evaluated, respectively. This study 104 highlights the effect of HLA-DP polymorphisms on the evolution of HBV genome during 105 chronic infection and also suggests that the HBV mutants affect the occurrence of HC and
106
HCC via interacting with the HLA-DP polymorphisms.
107

MATERIALS AND METHODS
108
Study participants. Healthy controls were recruited between September 2009 and November and HCC patients were diagnosed according to the criteria as previously described (1, 11).
117
HBsAg seroclearance subjects and ASCs were initially recruited from our community-based and HBV genotyping were carried out as previously described (20, 33) .
136
HBV mutation analysis. Amplification and sequencing of HBV EnhII/BCP/PC region 137 and preS region were carried out as previously described (11, 12, 33 Bonferroni correction.
190
RESULTS
191
Characteristics of the participants. Participant characteristics are listed in (TABLE 5) .
12
We then investigated the distribution of the HLA-DP SNP-affected HBV mutations in 247 the 4 clinical stages of HBV evolution. In the genotype C group, T1674C/G, A1846T, and
248
G1896A were more frequent in the patients with HBV-related liver diseases (CHB, HC, and
249
HCC) compared to ASCs (P < 0.001 for each comparison). The 3 mutations were more 250 frequent in the CHB patients than in the HC patients, respectively; while T1674C/G and
251
A1846T were more frequent in the HCC patients than in the HC patients. However, C1673T, alterations in viral activities. The same is true for A1846T (11). A31T, G105C, A135C, and 339 G147C lead to the aa substitutions at E133D, G158A/V, N168T, and G172A in the preS2 340 region, respectively. C10A, T49A, and C109A do not cause corresponding aa substitutions.
341
They might affect viral activities by altering potential transcription factor-binding sites (48).
342
G1896A introduces a stop codon W28end in the preC region, which impairs HBeAg significantly affected by the HLA-DP polymorphisms (TABLE 6 and TABLE 7 ). Significant HLA-DPA1 and HLA-DPB1 on HBV evolution.
381
To the best of our knowledge, it is the first study revealing that HLA-DP genetic HBV-infected subjects were relatively small. Thirdly, this study design was cross-sectional.
390
Further prospective studies are warranted to validate these findings.
391
In conclusion, the present study indicates that the HLA-DP genotypes promoting HBV Genome-wide association study confirming association of HLA-DP with protection 516 against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS. One. 
601
-This site is not a "hotspot" in given genotype.
602
a The wild-type nucleotide and the corresponding mutation at these "hotspots" exchanges between genotype B and genotype C. 
